- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/42 - Oxygen atoms attached in position 3 or 5
Patent holdings for IPC class C07D 211/42
Total number of patents in this class: 155
10-year publication summary
|
17
|
13
|
13
|
10
|
11
|
12
|
10
|
16
|
6
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Prilenia Neurotherapeutics Ltd. | 85 |
7 |
| Gen1e Lifesciences Inc. | 25 |
6 |
| Genentech, Inc. | 3979 |
5 |
| Xenon Pharmaceuticals Inc. | 188 |
5 |
| Janssen Pharmaceutica N.V. | 3396 |
4 |
| Massachusetts Institute of Technology | 10030 |
4 |
| Eli Lilly and Company | 3832 |
4 |
| Theravance Biopharma R&D IP, LLC | 460 |
4 |
| Bristol-myers Squibb Company | 4879 |
3 |
| Bayer Pharma AG | 1061 |
3 |
| The Broad Institute, Inc. | 1793 |
3 |
| Oregon Health & Science University | 763 |
3 |
| F. Hoffmann-La Roche AG | 7934 |
2 |
| Bayer Cropscience AG | 2051 |
2 |
| FUJIFILM Corporation | 29295 |
2 |
| Takeda Pharmaceutical Company Limited | 2712 |
2 |
| ABA Chemicals Corporation | 24 |
2 |
| Amicus Therapeutics, Inc. | 346 |
2 |
| Chiesi Farmaceutici S.p.A. | 966 |
2 |
| Council of Scientific & Industrial Research | 1424 |
2 |
| Other owners | 88 |